109 related articles for article (PubMed ID: 12013111)
1. C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study.
Vijayalakshmi N; Selvaluxmi G; Mahji U; Rajkumar T
Eur J Gynaecol Oncol; 2002; 23(2):135-8. PubMed ID: 12013111
[TBL] [Abstract][Full Text] [Related]
2. c-myc oncogene expression and clinical outcome in carcinoma of the cervix.
Sowani A; Ong G; Dische S; Quinn C; White J; Soutter P; Waxman J; Sikora K
Mol Cell Probes; 1989 Jun; 3(2):117-23. PubMed ID: 2671679
[TBL] [Abstract][Full Text] [Related]
3. c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma.
Brenna SM; Zeferino LC; Pinto GA; Souza RA; Andrade LA; Vassalo J; Martinez EZ; Syrjanen KJ
Braz J Med Biol Res; 2002 Apr; 35(4):425-30. PubMed ID: 11960190
[TBL] [Abstract][Full Text] [Related]
4. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
Hendy-Ibbs P; Cox H; Evan GI; Watson JV
Br J Cancer; 1987 Mar; 55(3):275-82. PubMed ID: 3552016
[TBL] [Abstract][Full Text] [Related]
8. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
9. [The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator].
Wu HJ
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):515-21. PubMed ID: 8754393
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.
Elwy AE; Elsaba TM; Abd Elzaher AR; Nassar MI
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3735-3746. PubMed ID: 31870116
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
Lin YC; Chen RY; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY; Chen SW
Anticancer Res; 2019 Jun; 39(6):3231-3240. PubMed ID: 31177173
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ
World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix.
Bourhis J; Le MG; Barrois M; Gerbaulet A; Jeannel D; Duvillard P; Le Doussal V; Chassagne D; Riou G
J Clin Oncol; 1990 Nov; 8(11):1789-96. PubMed ID: 2230867
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc gene product in gastric carcinoma.
Ninomiya I; Yonemura Y; Matsumoto H; Sugiyama K; Kamata T; Miwa K; Miyazaki I; Shiku H
Oncology; 1991; 48(2):149-53. PubMed ID: 1997938
[TBL] [Abstract][Full Text] [Related]
19. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
[TBL] [Abstract][Full Text] [Related]
20. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
O'Leary JJ; Landers RJ; Crowley M; Healy I; Kealy WF; Hogan J; Doyle CT
J Clin Pathol; 1997 Nov; 50(11):896-903. PubMed ID: 9462237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
